IMEMR
66.92
Volume 3, Issue 3 (2022)                   J Clinic Care Skill 2022, 3(3): 133-138 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hassanzadeh S, Hedayati F, Hosseini E, Malekzadeh J, Masnavi E, Keshtkari A. Association between IL-10 rs1800872 Polymorphism in the Promoter Region of Human IL-10 Gene and Susceptibility to Rheumatoid Arthritis in the Patients in Southwest of Iran. J Clinic Care Skill 2022; 3 (3) :133-138
URL: http://jccs.yums.ac.ir/article-1-147-en.html
1- “Department of Internal Medicine, School of Medicine” and “Social Determinants of Health Research Center” Yasuj University of Medical Sciences, Yasuj, Iran
2- Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran
3- Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
4- Department of Nutrition, School of Health, Yasuj University of Medical Sciences, Yasuj, Iran
5- “Department of Obstetrics and Gynecology, School of Medicine” and “Social Determinants of Health Research Center”, Yasuj University of Medical Sciences, Yasuj, Iran
6- Department of Paediatrics & Adolescent Medicine, Yasuj University of Medical Sciences, Yasuj, Iran , a_keshtkari@yahoo.com
Abstract:   (900 Views)
Aims: Interleukin-10 is an important immunoregulatory cytokine that has an inhibitory effect on the initiation and progression of inflammatory responses in different situations such as autoimmune diseases including rheumatoid arthritis. Polymorphism in IL-10 promoter region affects the expression of this gene. It therefore seems reasonable that these polymorphisms may contribute to rheumatoid arthritis susceptibility in special populations. the aim of this study was to investigate the association between IL-10 rs1800872 polymorphism in the promoter region of human IL-10 gene and susceptibility to rheumatoid arthritis in the patients in southwest of Iran.
Materials & Methods: The present study is a case-control study conducted among patients with and without rheumatoid arthritis referred to the Mofateh clinic in Yasuj, Iran. Both case (n=64) and control (n=65) groups were selected using purposive sampling and were matched in terms of age, gender and ethnicity. Peripheral blood samples were collected from subjects and rs1800872 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism method. SPSS 26.0 software was used for statistical analysis of data
Findings: The association between the frequency of TT genotypes and the incidence of rheumatoid arthritis was significant (OR=6.45; 95% CI= 1.30-32.00; p=0.023). On the other hand, the distribution of the T allele showed a significant relationship with rheumatoid arthritis (OR= 2.23; 95% CI= 1.26–3.97; p=0.006).
Conclusion: TT genotype of rs1800872 polymorphism is associated with rheumatoid arthritis susceptibility in southwestern Iranian population and can be considered as a risk factor for rheumatism.
 
Full-Text [PDF 1103 kb]   (1334 Downloads)    
Article Type: Original Research | Subject: Special
Received: 2022/07/29 | Accepted: 2022/09/20 | Published: 2022/09/19

References
1. McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328-37. [DOI:10.1016/S0140-6736(17)31472-1]
2. Dargham SR, Zahirovic S, Hammoudeh M, Al Emadi S, Masri BK, Halabi H, et al. Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. PloS One. 2018;13(12):e0208240. [DOI:10.1371/journal.pone.0208240] [PMID] [PMCID]
3. England BR, Mikuls TR. Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis. Up To Date. 2018.
4. van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med. 2009;7:12. [DOI:10.1186/1741-7015-7-12] [PMID] [PMCID]
5. Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347-69. [DOI:10.1016/j.yfrne.2014.04.004] [PMID]
6. Ehtesham N, Zare Rafie M, Esmaeilzadeh E, Dehani M, Davar S et al. Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus. Lupus. 2021;30(8):1273-82. [DOI:10.1177/09612033211014273] [PMID]
7. Castro-Santos P, Díaz-Peña R. Genetics of rheumatoid arthritis: a new boost is needed in Latin American populations. Rev Bras Reumatol Engl Ed. 2016;56(2):171-7. [DOI:10.1016/j.rbre.2015.10.004] [PMID]
8. Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for Rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3-18. [DOI:10.1016/j.berh.2017.08.003] [PMID] [PMCID]
9. Padyukov L. Genetics of rheumatoid arthritis. Seminars Immunopathol. 2022;44(1):47-62. [DOI:10.1007/s00281-022-00912-0] [PMID] [PMCID]
10. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-78. [DOI:10.1038/nature05911] [PMID] [PMCID]
11. Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59(1):89-101. [DOI:10.1080/10408398.2017.1358139] [PMID]
12. Chae DS, Park YJ, Kim SW. Anti-arthritogenic property of interleukin 10-expressing human amniotic MSCs generated by gene editing in collagen-induced arthritis. Int J Mol Sci. 2022;23(14):7913. [DOI:10.3390/ijms23147913] [PMID] [PMCID]
13. Hee CS, Gun SC, Naidu R, Gupta E, Somnath SD, Radhakrishnan AK. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between Rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol. 2007;17(5):429-35. [DOI:10.3109/s10165-007-0612-9]
14. Palivonaite M, Gedvilaite G, Glebauskiene B, Kriauciuniene L, Rovite V, Liutkeviciene R. IL-10 gene Rs1800871, Rs1800872, and Rs1800896 polymorphisms and IL-10 serum levels association with pituitary adenoma. Biomedicines. 2022;10(8):1921. [DOI:10.3390/biomedicines10081921] [PMID] [PMCID]
15. MacKay K, Milicic A, Lee D, Tikly M, Laval S, et al. Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology (Oxford). 2003;42(1):149-53. [DOI:10.1093/rheumatology/keg054] [PMID]
16. Ying B, Shi Y, Pan X, Song X, Huang Z, et al. Association of polymorphisms in the human IL-10 and IL-18 genes with Rheumatoid arthritis. Mol Biol Rep. 2011;38(1):379-85. [DOI:10.1007/s11033-010-0119-x] [PMID]
17. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for
18. differences in gene expression among ethnic groups. Nat Genet. 2007;39(2):226-31. [DOI:10.1038/ng1955] [PMID] [PMCID]
19. Jing L, Su L, Ring BZ. Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review. PLoS One. 2014;9(6):e97522. [DOI:10.1371/journal.pone.0097522] [PMID] [PMCID]
20. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81. [DOI:10.1002/art.27584] [PMID]
21. Okada, Wu D, Trynka G, Raj T, Terao C, et al. Genetics of Rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376-81. [DOI:10.1038/nature12873] [PMID] [PMCID]
22. Catrina AI, Deane KD, Scher JU. Gene, environment, microbiome and mucosal immune tolerance in Rheumatoid arthritis. Rheumatology. 2016;55(3):391-402.
23. Karlson EW, Ding B, Keenan BT, Liao K, Costenbader KH, et al. Association of environmental and genetic factors and gene-environment interactions with risk of developing Rheumatoid arthritis. Arthritis Care Res. 2013;65(7):1147-56. [DOI:10.1002/acr.22005] [PMID] [PMCID]
24. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG. Genetic polymorphisms in Spanish Rheumatoid arthritis patients: an association and linkage study. Genes Immun. 2003;4(2):117-21. [DOI:10.1038/sj.gene.6363931] [PMID]
25. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012; 32(1):23-63. [DOI:10.1615/CritRevImmunol.v32.i1.30] [PMID] [PMCID]
26. Opdal SH. IL-10 gene polymorphisms in infectious disease and SIDS. FEMS Immunol Med Microbiol. 2004;42(1):48-52. [DOI:10.1016/j.femsim.2004.06.006] [PMID]
27. Ciccacci C, Conigliaro P, Perricone C, Rufini S, Triggianese P, et al. Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by Rheumatoid arthritis. Clin Exp Immunol. 2016;186(2):157-63. [DOI:10.1111/cei.12831] [PMID] [PMCID]
28. Alvarez-Rodriguez L, Carrasco-Marín E, Tripathi G, Muñoz-Cacho P, Lopez-Hoyos M, et al. Influence of interleukin 10 promoter polymorphisms in polymyalgia rheumatica: disease susceptibility and functional consequences. Clin Exp Rheumatol. 2014;32(4):484-9.
29. Huizinga TWJ, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, et al. Are differences in interleukin 10 production associated with joint damage? Rheumatology. 2000;39(11):1180-8. [DOI:10.1093/rheumatology/39.11.1180] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.